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Pooled Testing for Effective Estimation of the Prevalence of Schistosoma mansoni
Shira Mitchell* and Marcello Pagano
Harvard University–Biostatistics, Boston, Massachusetts
Abstract. Rapid and accurate identification of the prevalence of schistosomiasis is key for control and eradication
of this devastating disease. The current screening standard for intestinal schistosomiasis is the Katz-Kato method, which
look for eggs on slides of fecal matter. Although work has been done to estimate prevalence using the number of eggs
on a slide, the procedure is much faster if the laboratory only reports the presence or absence of eggs on each slide.
To further help reduce screening costs while maintaining accuracy, we propose a pooled method for estimating preva-
lence. We compare it to the standard individualed method, investigating differences in efficiency, measured by the
number of slides read, and accuracy, measured by mean square error of estimation. Complication is introduced by the
unknown and varying sensitivity of the procedure with population prevalence. The DeVlas model for the worm and
egg distributions in the population describes how test sensitivity increases with age of the epidemic, as prevalence and
intensity of infection increase, making the problem fundamentally different from earlier work in pooling. Previous
literature discusses varying sensitivity with the number of positive samples within a pool, known as the “dilution effect.”
We model both the dilution effect and varying sensitivity with population prevalence. For model parameter values
suited to younger age groups, the pooled method has less than half the mean square error of the individualed method.
Thus, we can use half as many slides while maintaining accuracy. Such savings might encourage more frequent mea-
surements in regions where schistosomiasis is a serious but neglected problem.
INTRODUCTION
Schistosomiasis (also known as Bilharzia) is a chronic dis-
ease caused by parasitic worms. Its intestinal form is respon-
sible for severe liver and intestinal damage, physical growth
retardation, and cognition and memory problems. The World
Health Organization (WHO) reports that more than 200 mil-
lion people are infected worldwide and an estimated 700 mil-
lion people are at risk of infection because of their residence
in tropical and subtropical areas, and in poor communities
without access to safe drinking water and adequate sanita-
tion. Young children are especially vulnerable to infection
because of their hygiene and play habits, and the symptoms
are quite harmful to them, impairing learning ability and physi-
cal development, and even sometimes causing death.
The current WHO strategy for schistosomiasis control focuses
on reducing disease through periodic, targeted treatment with
praziquantel. The WHO guidelines identify three strategies
based on community prevalence of infection: 1) in communi-
ties with a high prevalence (more than 50% infected, we call
the high group) universal treatment is conducted once a year;
2) in communities with a moderate prevalence (more than
20% infected but < 50%, we call the moderate group) school-
age children are treated once every 2 years; and 3) in com-
munities with a low prevalence (< 20% infected, we call the
low group) chemotherapy should be available in health facili-
ties for treatment of suspected cases.
1 To implement the
WHO strategy, we must effectively classify each community
into one of these three categories. A strategy for achieving
this aim is the subject of this work.
True prevalence of active infection is defined as the propor-
tion of individuals with at least one worm-pair (one male and
one female, otherwise if only one gender is present, they
cannot reproduce). Most control programs are based on the
detection of eggs by fecal smears on 47 mg slides using the
Kato-Katz technique. The observed prevalence is defined as
the proportion of individuals who show at least one positive
egg count.
2 In contrast, the observed prevalence is dependent
on the quantity of stool examined in the sample, the number
of samples collected (and at which time intervals), and the
average worm load (indirectly measured by intensity—eggs/g
feces). This is caused by the possibility that a person has
worms but that eggs are not present in the stool on a given
day, or the eggs are present in the stool, but not in the smear
taken from the sample and placed on the slide, or the eggs
are on the slide but not seen by the reader. Thus, one has to
be careful when designing policy based on observed preva-
lence. To be concrete, and motivated by the interest in the
propagation of the infection, we focus on prevalence as the
percentage of individuals with at least one worm-pair. In this
way, we can compare prevalence estimates using different
algorithms by adjusting the observed prevalence appropri-
ately. Population-level treatment and control are dependent
on the measurement of prevalence, thus it is important to
investigate the ways of making the measurement as accu-
rately as one can within a reasonable budget, and that is the
goal of this work.
Current WHO recommendations for estimating prevalence
are based on sample surveys of 50 children/school within
the defined ecological zones
1; this sample size was possibly
selected because it was considered to be the number of
sample slides that a survey team examines in a single day.
Such an approach typically involves a survey team of sev-
eral staff moving with a single vehicle, and necessitates
entry and analysis of survey data. It is therefore often con-
sidered prohibitively expensive for a national program to
sustain parasitological surveys on a large scale when this
approach is used.3
To reduce screening costs by reducing the number of
slides examined, but at the same time not sacrificing any
accuracy, we propose a new way to measure prevalence of
schistosomiasis that we call pooled testing. The current stan-
dard, against which we contrast our proposed method, we
call individualed, and it examines 47 mg of feces per slide,
*Address correspondence to Shira Mitchell, 655 Huntington Ave.,
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850taken as four snips from one child’s fecal sample smeared on
a slide. The pooled method combines snips, of about 12 mg
each, from separate fecal samples from four children smeared
on a single slide. Both techniques have an observed prevalence
that will underestimate the true prevalence (based on the
worm-pair definition). Thus, we need to adjust either estimate
(the individualed or the pooled) upward to overcome the bias
and come closer to the true prevalence.
Previous literature on pooling methods discusses the vary-
ing sensitivity of the pooled test with the number of positive
samples within a pool. This is known as the “dilution
effect.”
4 Our model takes into account both the dilution
effect and the varying sensitivity of the test with intensity
of infection, as modeled by the DeVlas model introduced in
the next section.
The model. The goal of this work is to estimate the true
prevalence, the proportion of individuals with at least one
worm-pair. The data consist of positive (eggs found) or nega-
tive (eggs not found) readings of fecal smear slides, however
the slides are constituted. We need to understand the relation-
ship between the true prevalence and probability that eggs are
found in the laboratory testing procedure (the sensitivity).
Thus, it is necessary to model how the number of eggs per fecal
sample varies from person to person and from day to day.
To this end, let P(Y = y; h0x,r) be the probability of find-
ing y eggs in a stool smear (~12 mg of fecal matter) from
ap e r s o nw i t hx worm-pairs. Let h0 be the number of eggs
per smear per worm-pair. Note that the distribution of Y
incorporates the variability in egg output in the stool, the
variability in the number of eggs captured in the smear, and
the variability in what the laboratory technician can actually
count. DeVlas considers the negative binomial model where
Y ~ NegBin(h0x,r)w i t hm e a nh0x and index of aggregation
r,
5 because r (the index of aggregation in the distribution of
egg counts) increases, the variance decreases. The parameter
r can also account for imprecision in the measurement of
12 mg of fecal matter per smear. For example, if one smear
is actually 16 mg, and another is 8 mg, the difference in egg
counts from smear to smear is more variable, which can be
built into the model with a smaller value for r.W es e eb e l o w
in simulations that the relative benefit of pooling (compared
with the individualed method) does not seem to be sensitive
to the value of r.
If nm and nf represent the number of male and female
worms, respectively, (n = nm + nf) then x = min(nm,nf)
is the number of worm-pairs. DeVlas considers nm and
nf ~ Bin(n,1/2). Let P(X = xjN = n) be the probability of
having x worm-pairs for an individual with worm load n.
Let P(N = n; M,k) be the probability of having n worms.
Let N ~ NegBin(M,k) have mean M and index of aggrega-
tion k.A sk (the index of aggregation in the distribution of
worms in the population) increases, the variance decreases.
Small values of k indicate more aggregation and relative
overdispersion, with the worm counts highly concentrated in
a small section of the population. This situation arises in
populations with a low level of immunity, where variation
in exposure is not countered by the development of immu-
nity. Such low levels of immunity are seen in younger age
groups, where there are lower values of k
5; another reason
there could be a high level of overdispersion in worm load
(i.e., a low value for k) would be community variation in
exposure to infection. Such heterogeneity could arise from
a community being composed of a variety of occupations.
5
Thus, when modeling the value of k in a community; one
should consider age and homogeneity of exposure. If one
chooses to perform Bayesian inference (rather than maxi-
mum likelihood), one might then have a prior distribution
on k and the prevalence p, which together can be used
to compute a prior distribution for M (because prevalence
p is a function of k and M). We explore this Bayesian for-
mulation further in Reference 6. The overall distribution of
the number of eggs per smear (y)i sP(Y = y; M,k,h0,r)( s e e
the Appendix in Reference 5).
Let c be the number of smears per slide. In the litera-
ture, c is referred to as the composite sample size, or the
pool size. We focus on the case of c = 4 because of com-
mon field practice, but our derivations are kept general and
our simulation program can accommodate other values of c.
To describe collecting c = 4 smears from 1 person on the
same day we refer to h0 as the number of eggs per smear
per worm-pair, so h = ch0 is the number of eggs per slide
(i.e., sample) per worm-pair. We define prevalence as the
probability of having at least one worm-pair, so p = P[X > 0]
(see Reference 7, Box 1.) We define the c-smear sensitivity
as the sensitivity when using c smears from the same indi-
vidual. See Appendix for mathematical details to derive an
expression for sensc,t h ec-smear sensitivity.
INDIVIDUALED PREVALENCE ESTIMATOR
In this section we discuss the estimator of prevalence using
the individualed method. Let P1 be the probability of a posi-
tive slide, which is a function of the prevalence p.L e tm be the
number of slides tested and W t h en u m b e ro fp o s i t i v es l i d e s ,
with W
―
= W/m . Letting sens4 = Pr[Y1 + Y2 + Y3 + Y4 > 0jX > 0]
be the sensitivity of the test using the individualed method
with four smears from one person, we see that P1(p)i s
P1(p) =Pr[at least one smear has eggs]
=Pr[Y1 + Y2 + Y3 + Y4 > 0]
=Pr[Y1 + Y2 + Y3 + Y4 > 0 j X > 0]Pr[X > 0]
=sens4 *p,
(1)
because we assume no “eggs” will be spotted in a smear
coming from a person with no worm-pairs, and thus take the
specificity of the measurements to be one—i.e.,
Pr[find no eggs in smearjperson has no worm-pairs] =
P[Y = 0jX = 0] is 1. Solving for p we have the MLE,
b p1 = W
―
/sens4, which is unbiased, if we know sens4. The
variance is
Var(b p1) = p(1   sens4p) =(m sens4), (2)
if the sens4 used in the estimator is the true sensitivity.
Note that b p1 might be greater than one. Therefore, define a
truncated estimator,
  p 1 =
W
―
sens4
W
―
£ sens4
1 sens4 < W
―
£ 1:
8
> > <
> > :
For values of the parameters we are investigating,
P(sens4 < W
―
) is zero up to at least two significant digits, and
EFFECTIVE ESTIMATION OF S. MANSONI PREVALENCE 851furthermore, it will be obvious we are in this unlikely case
if our prevalence estimate is greater than 1, so we focus on
the non-truncated b p henceforth.
POOLED PREVALENCE ESTIMATOR
Now consider the estimator of prevalence using the pooled
method. Define W as before, with the probability of a posi-
tive slide in the pooled case (the subscript “c” denotes that
the slide consists of smears from c separate individuals).
Again, we maximize the likelihood to get b Pc =b Pcð pÞ = W
―
.
Letting sens1 = P[Y > 0jX > 0] = P[Y > 0]/P[X > 0] (the
sensitivity for a single smear), and recalling that the speci-
ficity is one,
Pr[³ 1smear tests positive j jhave worms] =1   Pr[no smear tests positive j j have worms]
=1   (1   P[Y > 0 j X > 0])
j
=1   (1   sens1)
j,
and
Pc = Pc(p) = Pr[³ one smear tests positive]
=(
c
j=0
Pr[³ one smear tests positive j j have worms]Pr[j have worms]
=(
c
j=0
[1   (1   sens1)
j]
c
j
  
pj(1   p)
c j
=(
c
j=0
c
j
  
pj(1   p)
c j  (
c
j=0
c
j
  
((1   sens1)p)
j(1   p)
c j
= (p + 1   p)
c   ((1   sens1)p + (1   p))
c
= 1   (1   sens1 * p)
c (3)
Solving for p we have the MLE, b pc = (1   (1   W
―
)
1=c)=sens1,
which is biased (see Bias and bias correction section and
Reference 8). The truncated estimator is
  pc =
1   (1   W
―
)
1=c
sens1
1   (1   W
―
)
1=c £ sens1
11   (1   W
―
)
1=c > sens1
8
> <
> :
(4)
Although it is possible that 1   (1   W)
1=c > sens1, for
likely values of model parameters, it is a very unlikely
event. It will be obvious we are in this unlikely case if our
prevalence estimate is greater than 1. Thus, we focus on the
estimator b pc.
Bias and bias correction. Recall that c is the number
of smears per slide. In the pooled method we propose,
we can consider a slide to be a pool, as in the literature
(see References 8–11 for more about pooled testing). Note
that our setting differs from the settings in the literature,
which either uses a prefect test or a test whose sensitivity
does not get diluted in a pool, which is a more realistic
model in our setting of testing for estimation of schistoso-
miasis prevalence.
Let Pc be the probability of a positive slide in the pooled
case. With a perfect test, a slide is negative if and only if all c
individuals are not infected, therefore 1   Pc = (1   p)
c,o r
p = 1   (1   Pc)
1=c. The quantity H(Pc) = 1   (1   Pc)
1=c is
called the prevalence transformation.
8 It takes the proba-
bility of a positive pool and transforms it to the probability
of a positive individual. Because we are assuming a test
with imperfect sensitivity (i.e., sens1 < 1), we denote the
prevalence transformation in our case (with Pc given by
Eq. [3]) by H
~
. For c > 1, H(t) (and H
~
(t)) is monotone
increasing in t,s ow ec a nr e d u c et h eb i a si nb pc by shrinking Pc
toward zero before applying the prevalence transformation.
8
The shrinking estimator is b p
* = H
~
(W
―*) where W
―*= aW
―
for
some a,0£a£1. A natural choice is a = 1   b=(n + d), for
some positive numbers b,d, which act as adjustable param-
eters to regulate the degree of shrinking. For the Burrows’
estimator b pB = H
~
(W
―B) where W
―B = 1   b=(n + b) W
―
there-
fore a = 1   b=(n + b), in other words, it is the shrinking esti-
mator where we choose b = d.W ec h o o s eb to eliminate the
order n 1 term in the bias (substituting in W
―B into the above
Taylor expansion of H
~
(t) to evaluate the Bias(p ~), and get
b = (c   1)=(2c), see Reference 8 for details.
p ~
c =
1
sens1
1  
2c(m   mW
―
) + c   1
2cm + c   1
 ! 1=c 0
@
1
A= H
~
(W
―B), ð5Þ
compare with b pc in Eq. (5), our more biased estimator:
b pc =
1   (1   W
―
)
1=c
sens1
ð6Þ
We plot the percent bias in the prevalence estimator for b pc
and p ~
c for c = 4 in Figure 1. The bias of the MLE is
Bias( b pct) = E[b pc   p]
=(
m
x=0
[H
~
(W
―
)   p]
m
x
  
Px
c(1   Pc)
m x
=(
m
x=0
1   (1   W
―
)
1=c
sens1
  p
2
4
3
5 m
x
  
Px
c(1   Pc)
m x
852 MITCHELL AND PAGANOif the sens1 used in the estimator is the true sensitivity. The
bias of the Burrows estimator is
Bias(p ~
c) = E[p ~
c p]
=(
m
x=0
½H
~
(W
―B) p 
m
x
  
Px
c(1 Pc)
m x
=(
m
x=0
1
sens1
1 
2c(m x) + c 1
2cm + c 1
0
@
1
A
1=c 0
B @
1
C A p
2
6 4
3
7 5
m
x
  
Px
c(1 Pc)
m x
(again, if sens1 is the true sensitivity.) The percent bias is
100*Bias(estimator)=p. We choose to use the Burrows cor-
rection for the pooled estimator because it significantly
reduces the bias in the pooled estimator. Thus, when deal-
ing with the case of taking more than 15 slides per school,
expect the bias of the Burrows-corrected estimator to be
nearly zero.
Key point. The maximum likelihood estimator (MLE) over-
estimates the prevalence; therefore, we use the Burrows esti-
mator (a type of so-called “shrinking estimator”) that shrinks
the estimate slightly, to reduce the bias of our estimator.
Asymptotic MSE ratio of the estimators. Because one com-
ponent of the screening costs for schistosomiasis is domi-
nated by the number of slides examined, we wish to know
which technique gives a more accurate estimate of preva-
lence (and risk category) given the same number of slides.
To evaluate the effect of pooling we examine the ratio of the
asymptotic mean square error (MSE) for the pooled estimator
(p ~
c) to the asymptotic MSE for the individualed estimator
(b p1). Again, in this section we assume that the sensc and
sens1 used in the estimators are the true sensitivities. From
the Individualed Prevalence Estimator section, we know that
b p1 is unbiased with the computed variance. Thus, we get the
MSEs from the variance for the individualed estimator
Eq. (2), which is unbiased, and
MSE(p ~
c) = E[(p ~  p)
2]
=E
H(W
―B)
sens1
 
1   (1   Pc)
1=c
sens1
0
@
1
A
2 2
4
3
5
=
1
sens2
1
E[(H(W
―B)   H(Pc))
2]
=
1
sens2
1
MSE(H(W
―B)) using Taylor expansions as in [8],
=
1
sens2
1½
(1   sens1p)
2 c(1   (1   sens1p)
c)
mc2
+
(c   1)
2(1   sens1p)
2 2c(1   (1   sens1p)
c)
2
2m2c4 + O
1
m3
0
@
1
A 
=
1
sens2
1
(1   sens1p)
2 c(1   (1   sens1p)
c)
mc2
+
1
sens2
1
(c   1)
2(1   sens1p)
2 2c(1   (1   sens1p)
c)
2
2m2c4 + O
1
m3
0
@
1
A
Then, the asymptotic ratio (as m !1 )i s
MSE(p ~
c)
MSE(p1)
=
sensc(1 sens1p)
2 c(1 (1 sens1p)
c)
sens2
1c2p(1 senscp)
+ O
1
m3
  
:
We plot this asymptotic MSE ratio, as a function of the
prevalence p, for c = 4, and for three different values for the
sensitivities, sens4 and sens1 (see Figure 2). We choose values
to show the case of a perfect test, values from the literature,
12
which found that “the overall sensitivity of a single Kato-
Katz smear was 70.8%, and it increased with each additional
slide to reach 91.7% on examining four smears,” and finally,
values to indicate a lower range of sensitivity, because our
Figure 1. Percent Bias in the MLE (b pc, thin lines) and Burrows
(p ~
c, bold lines) estimators for pool size c = 4 as a function of number
of slides (m) for low, moderate, and high prevalence settings: Using
the Burrows estimator results in a reduction in finite sample bias.
Note that beyond m = 15 slides the bias is nearly zero.
Figure 2. MSE ratio pooled to individualed: For three example
settings of the sens4 and sens1.
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12 to fit all smears onto
a single slide. Of importance, the sensitivities from Refer-
ence 12 were based on a single stool sample, so the relative
change in sensitivity when increasing to four times the fecal
matter can be expected to be similar. Increasing the number
of stool samples across time has been found to increase the
sensitivity more drastically.
13 Figure 2 shows that the MSE of
the pooled estimator is roughly half that of the individualed
estimator at prevalences below roughly 30%. This is of inter-
est because we can read half as many slides to achieve the
same accuracy of prevalence estimation. Note that we are in
some sense making an unfair comparison because the slides
from the pooling technique use fecal matter from more
individuals. However, the comparison is the comparison of
interest because the cost is dominated by the cost of slides
and the cost of reading each slide not on the amount of
fecal matter used.
Note also that with a perfect test, below prevalences of
roughly 50%, the pooled estimator has smaller asymptotic
MSE than the individualed estimator. The poor performance
of a pooled estimator at high prevalences has been well
studied (see References 8–11) and results from the fact that
getting all positive pools is not informative. Note however,
this upper bound gets higher as the sensitivities decrease,
because lower sensitivity lowers the probability of all posi-
tive pools.
Intuitively, the four smears from the same individual may
be redundant, because egg counts per smear are positively
correlated.† The DeVlas model described previously accounts
for this because of the correlation of egg counts within an
infected individual. Thus, in general, sens4 < 1   (1   sens1)
4.
This holds for the observed sensitivities in Reference 12
where 0:917 < 1   (1   0:708)
4 = 0:993 and more extremely
for 0:6 < 1   (1   0:4)
4 = 0:8704, our third example of sensi-
tivities. We see in Figure 3 that this property of the sensi-
tivities pushes the curve downward, making pooling more
efficient relative to not pooling. Furthermore, as sens1 gets
closer and closer to sens4, we get closer and closer to the
usual pooling setting in which it is assumed that sensitivity
does not decrease with pooling. In other words, having
only one infected smear on a slide is just as easily detected
as having four infected smears. This is likely not true in
general for schistosomiasis, but may be close to true in
situations of a high intensity of infection, when infected
people have many worms, which therefore produce many
eggs. This is likely to hold true in regions where there has
been no treatment available for a long time, so infections
have been allowed to grow stronger and worms have mul-
tiplied enormously. Thus, assuming constant and known
values for sens1 and sens4 for the population, we see from
the previous derivation that pooling is much more efficient,
allowing for reading half the slides to achieve the same
level of accuracy.
In Figure 4, we examine the effect of decreasing to a pool
size of c = 2. We obtain values for sens1, sens2, sens4 by
the DeVlas model with parameters M = 500, k = 0:2,
h0 = 0:085, r = 1:6, and plot the ratio of pooled/individualed
MSE for a pool size of two and four. We see that a pool size
of two is less beneficial for lower prevalences, but does
slightly better at higher prevalences (above roughly 50%).
Because we are most likely dealing with prevalences below
50% (and those above 50% are all treated the same according
to the WHO recommendations), we decided to proceed with
t h ep o o ls i z eo ff o u r .B e y o n df o u ri sl i k e l yi n f e a s i b l ea sa
laboratory procedure.
Figure 2 assumes constant values for sens4 and sens1,
which are known and chosen correctly in the estimators. In
reality however, they depend on the parameters M,k,h0,r.
Figure 3. MSE ratio pooled to individualed: Comparing sens4 <
1   (1   sens1)
4 to sens4 = 1   (1   sens1)
4.
Figure 4. MSE ratio pooled to individualed: Comparing c = 4t o
c = 2 for sens4 = 0:88, sens2 = 0:83, and sens1 = 0:76.
†If one smear has eggs, then the individual is clearly infected (i.e., has
worms), and the worms are producing eggs on that day, so the stool
contains eggs. Thus, the other three smears are more likely to have
eggs and therefore to provide redundant information.
854 MITCHELL AND PAGANOBecause we do not know the parameter values, we do
not know the true values of sens4 and sens1 or the true
prevalence. Because prevalence is a function of M and k,
the values for sens4 and sens1 will change with the preva-
lence. The asymptotic expression for MSE above does not
incorporate this added complexity. To get a picture of how
the MSE ratio behaves with a finite number of slides (we use
the current standard of m = 50 slides) and to explore how the
MSE ratio is affected by varying the parameters M,k,h0,r in
the model, we turn to simulations.
Key point. The mean square error of an estimator measures
the square of the average amount by which the estimator
misses the quantity we are trying to estimate (for us, the
prevalence). It plays the role of the variance when dealing
with a biased estimator. By asymptotic, we mean we examine
this error as the sample size approaches infinity. We compare
the pooled and individualed estimators by their asymptotic
mean square error to see which one does better at estimating
prevalence as the sample size approaches infinity. Figure 2
shows us that the mean square error of the pooled estimator
is roughly half that of the individualed estimator at preva-
lences below roughly 30%. This is of interest because we can
read half as many slides to achieve the same accuracy of
prevalence estimation.
Figure 5. Relative Variance: (A) Relative Variance, changing M;( B) Relative Variance, changing k;( C) Relative Variance, changing h;
(D) Relative Variance, changing r.
EFFECTIVE ESTIMATION OF S. MANSONI PREVALENCE 855SIMULATIONS
For each plot, we fix three of the four parameters M,k,h0,
and r and vary the fourth parameter to study the variance,
bias, and MSE change for the pooled and individualed esti-
mators. In contrast to the asymptotic analysis, we now allow
the true sensitivities to vary with the varying parameter
values. In other words, for the individualed method, we pick
a random number of worms for the individual (from the
Negative Binomial in the DeVlas model above), and given
this worm count pick an egg count for a quantity of 47 mg of
stool. If this count is nonzero, we say we have a positive test
result. Thus, in our simulation we allow each individual in a
population to have their own sensitivity, which is a function
of their own worm count, in other words: sens(x) =
P[Y > 0 j X = x]. Similarly, in the pooled method, we pick
four random numbers of worms and for each of these worm
counts we pick egg counts for a quantity of 12 mg of stool.
Note, of course, that the estimators of prevalence must have
fixed values for sens4 and sens1, so we estimate them based on
parameter values in the center of the ranges over which they
vary. Thus, we expect the bias to be near zero in a neighborhood
of these values (where we “guess” the sensitivities correctly) and
Figure 6. Comparing the Bias. (A) Bias for individualed, changing M;( B) Bias for pooled, changing M;( C) Bias for individualed, changing k;
(D) Bias for pooled, changing k.
856 MITCHELL AND PAGANOto get larger in absolute value as the parameter values deviate
further from these center values.
We ran 5,000 simulations for each value of the four
parameters. We chose parameter values to be representative
of populations of young children in sub-Saharan Africa, and
prevalences between 0 and slightly above 50%, because
prevalences well above 50% are easily identified. At
k = 0:2 and M = 20, the prevalence is ~50%, the boundary
between the moderate and high groups. We see that in
general we might expect lower values of k, the aggregation
parameter, among younger children, so we focus on such
lower values of k (see Reference 5). We fix h = 0:05 (for
four smears, h0 = 0:05=4 for one smear), which reflects an
egg per worm-pair output typical of Africa and the African
diet (see Reference 5, p. 456). Finally, we choose r = 1:6
to reflect a moderate level of variability of egg counts for
an individual.
Comparing the variance of the pooled to the individualed
estimator, in Figure 5B, we see that holding M = 20 fixed and
changing k from 0 to 0.5, we have a relative variance (pooled
to individualed) that drops to roughly 0.65.
Changing h0 and r does not change the prevalence, and
in Figure 5C and D we look at a prevalence of 49% (near
50% cutoff). As h0, the egg output per worm-pair increases,
Figure 7. Comparing the Bias: (A) Bias for individualed, changing h;( B) Bias for pooled, changing h;( C) Bias for individualed, changing r;
(D) Bias for pooled, changing r.
EFFECTIVE ESTIMATION OF S. MANSONI PREVALENCE 857the relative variance increases but remains well below 1.
As r, the aggregation for egg output, increases (meaning that
egg output variability decreases) the relative variance increases
slightly, but the correlation does not appear very strong.
Figures 6 and 7 compare the bias of the individualed and
the pooled estimators. Both have zero bias at the parameter
values chosen to estimate the sensitivity (sens4 and sens1). We
can see that the sens1 = P[Y > 0 j X > x] = P[Y > 0]/P[X > 0]
is more sensitive to choice of parameters (M,k,h0, and r)
than sens4 = Pr[Y1 + Y2 + Y3 + Y4 > 0]/Pr[X > 0], therefore
the bias will usually be worse in the pooling case if we do not
know the values for M,k,h0,r.
Comparing the MSE of the pooled and individualed estima-
tors in Figure 8 we see that the relative MSE is mostly below 1,
even where the bias of the pooled estimator is higher than
the individualed, because the variance of the pooled esti-
mator is much lower than the variance of the individualed
estimator. This argues for preferring the pooled estimator
over the individualed estimator.
ESTIMATING PREVALENCE
We are trapped in circularity when trying to estimate prev-
alence, because we need to know the prevalence to know
Figure 8. Relative MSE:( A) Relative MSE, changing M;( B) Relative MSE, changing k;( C) Relative MSE, changing h;( D) Relative MSE,
changing r.
858 MITCHELL AND PAGANOthe sensitivity, which is required to estimate the prevalence
unbiasedly. Below we suggest a method to arrive at an esti-
mate of prevalence that takes into account the dependence of
sensitivity on the prevalence by using an iterative technique.
We need values for sens4 or sens1 to report an unbiased
individualed or pooled estimate, respectively. However, sens4
and sens1 are functions of the model parameters M,k,h0,r,
and in particular, vary greatly with prevalence (a function
of M,k). Thus, to estimate prevalence unbiasedly, we are
required to already know the prevalence, an obvious cir-
cularity. In an attempt to combat this problem, we begin
with an initial guess at the prevalence b p0 (say, the observed
prevalence, i.e. ignoring the sensitivity issue). With some
knowledge of our population (age group, etc.) we set k, the
aggregation parameter, and using p0 get a value for M.O n
the basis of these k,M we compute the corresponding sens
0 ðÞ
4
and sens
0 ðÞ
1 based on ^ p0. We can then use these sensitivities
to get a new estimate of prevalence b p1 and again use this
to compute corresponding sens
1 ðÞ
4 and sens
1 ðÞ
1 . We can con-
tinue in this iterative manner until we converge to an estimate
of prevalence. If we start close enough to the unbiased preva-
lence, this method will converge to the unbiased prevalence.
We can define f(p)   EW
―
=sens4(p), so pn+1 = f(pn). The
prevalence is a fixed point of f. From numerical analysis,
we know that f converges to the fixed point p (the true prev-
alence) if f is continuously differentiable in an open neigh-
borhood of a fixed point p andj f ¢(p)j< 1 (see Reference 14,
pp. 226–233). This property is usually difficult to prove, so
we recommend performing a few iterations (which are very
fast) and assessing convergence.
Similarly for the pooled case, where we define
f
~
(p)  
1
sens1(p)
E 1  
2c(m   mW
―
Þ + c   1
2cm + c   1
 ! 1=c 0
@
1
A:
For large enough sample sizes the bias of the Burrows estima-
tor is essentially zero, so we may assume we want the fixed
point here as well to get the true prevalence. Again, to prove
convergence, one must check that f
~
is continuously dif-
ferentiable in an open neighborhood of a fixed point p and
that j f
~
¢(p)j< 1.
We are not given the true EW
―
or Eð1   ð2c(m   mW
―
Þ +
c   1=2cm + c   1Þ
1=cÞ but these can be consistently esti-
mated by w
― and 1  2c(m mw
―)+c 1=2cm+c 1 ðÞ
1=c
  
so
we can expect convergence to b p such that w
―=sens4(p) = p
and 1=sens1(p)1   2c(m mw
―)+c 1=2cm+c 1 ðÞ
1=c
  
= p,
respectively. These iterations do not take long to converge
and the result is an estimate of prevalence that takes into
account the variance of sensitivity with prevalence.
SIMULATIONS FROM FIELD DATA
We used school-level data from schools in Uganda
(296 schools, average prevalence of Schistosoma mansoni
per school: 28%
15), Tanzania (143 schools, average preva-
lence of S. mansoni per school: 4.4%
16), Mali (454 schools,
average prevalence of S. mansoni per school: 10%
17), and
Cameroon (402 schools, average prevalence of S. mansoni
per school: 7.3%
18).
Using data from these four countries we compiled a list of
1295 schools with the measured prevalences from the field.
For the purpose of simulation, we took these prevalences to
be truth (likely an underestimate, because of the poor sensi-
tivity of the test). For each school we performed five methods:
testing of 12, 25, and 50 individualed slides, and testing of
12 slides composed of four children each, and testing of
25 slides composed of four children each. We used 0.9 for
the 4-smear sensitivity (sens4) and 0.7 for the single-smear
sensitivity (sens1), as was found in Reference 12. We use a
simplifying assumption that this sensitivity is constant and
known. We preformed 5,000 simulations, and report the
average results in Table 1. It provides evidence of the bene-
fits of pooling.
We summarize the results in two summary measures (see
Table 1 below): the L1 distance between the vector of true
prevalences at the schools and the estimated vector of preva-
lences using the sampling method, and the number of mis-
classifications into the incorrect WHO prevalence category.
Note that pooling with 25 slides classification accuracy
close to the accuracy of 50 slides using the individualed
method (only five more misclassifications), whereas drop-
ping to 25 individualed results in 22 more misclassifications.
Furthermore, the L1 distance from truth for 25 pooled is some-
where between the L1 accuracy of the 25 and 50 individualed
slides methods, but closer to the 50 individualed accuracy.
We see that the relative benefits of pooling in terms of
classification change with the priors and assumptions about
varying sensitivity with prevalence (see Reference 6).
DISCUSSION
Previously, we have shown (in Asymptotic MSE ratio of
the estimators section) that if one assumes constant and
known sensitivities (per smear sens1 and per slide, sens4)
the MSE of the pooled estimator is then roughly half that
of the individualed estimator at prevalences below roughly
30%. The pooled estimator has a lower MSE than the
individualed estimator up to roughly 50% prevalence (and
higher as the sensitivities decrease, because that lowers
the probability of all positive pools). This is of interest
because we can read half as many slides to achieve the
same accuracy of prevalence estimation in regions with
below 30% prevalence. (It may be most important to moni-
tor the prevalence in these regions below 30%, because
above 30% it will be easy to determine that treatment of
the region is necessary and that appropriate actions be
taken.) We see that as the relative difference between
the sensitivity from a single smear (sens1) and the sensi-
tivity of an entire slide (sens4) becomes smaller, the relative
Table 1
Comparison of methods using real data
Method jp   pj1 # Misclassified
12 slides, individualed 53 96
25 slides, individualed 37 67
50 slides, individualed 26 45
12 slides, pooled 41 72
25 slides, pooled 30 50
EFFECTIVE ESTIMATION OF S. MANSONI PREVALENCE 859benefits of pooling are increased. The DeVlas model can
provide insight into when these sensitivities are closer or
farther apart.
Furthermore, the DeVlas model allows us to simulate
the reality that sensitivity is not constant and known. We
see in Simulations section that the pooled estimator gen-
erally outperforms the individualed, when using the same
number of slides. Varying each parameter value in the DeVlas
model allows us to see how the variance, bias, and MSE
change for the pooled and individualed estimators. The dif-
ficulty with estimating prevalence with an unknown sen-
sitivity that changes with prevalence does create a problem
for either the pooled or individualed estimators and more
work needs to be done to understand how to circumvent
this issue.
Latent class (LC) analysis has been used to deal with the
issue of unknown test sensitivity. It can be used when several
diagnostic tests are available, as was done in Reference 19.
Such methods have been extended to the case where sen-
sitivity varies by group (such as location, gender, or age).
20
We model sensitivity explicitly as a function of prevalence,
which may be possible to incorporate into the LC methods.
When using the same number of slides read, for preva-
lences below, we achieve better accuracy with pooled esti-
mators than the standard individualed estimator for the
prevalence of schistosomiasis, even if the test sensitivity does
decrease with pooling. The relative benefit of pooling depends
upon prevalence, how much the single smear sensitivity (sens1)
differs from the slide sensitivity (sens4). Further investigation
is needed to determine in which regions these benefits are
greatest, and whether there is added complexity and cost intro-
duced by the laboratory procedure of creating a pooled slide
rather than an individualed slide.
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APPENDIX: C-SMEAR SENSITVITY
We now compute the sensitivity of the test when taking
c smears from the same individual, which we call the c-smear
sensitivity, or sensc. We use the distributions defined pre-
viously in The model section from the DeVlas model. Recall
that h0 is the number of eggs per smear per worm-pair.
860 MITCHELL AND PAGANOsensc = Pr[Y1 +...+ Yc > 0jX > 0;M,k,h0,r]
=1   Pr[Y1 = 0,...,Yc = 0jX > 0;M,k,h0,r]
=1   Pr[Y1 = 0jX > 0;M,k,h0,r]
=1  
P[Y = 0;M,k,h0,r]   Pr[Y1 = 0jX > 0;M,k,h0,r]P[X = 0;M,k]
P[X > 0;M,k]
=1  
(
1
x=0
r
hx + r
0
@
1
A
r
K(x)   (1   p)
p
where h = ch0, the number of eggs per sample (i.e. slide)
per worm pair
with K(x) =(
1
n=2x
G(k + n)
G(x+1)G(n   x+1)G(k)
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which does not depend on c:
= 1  
(
1
x=0
r
ch0x + r
0
@
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A
r
*K(x)   (1   p)
p
where G(:) represents the gamma function, a component of
various probability distributions and defined as G(z) = Ð 1
0 e ttz 1dt for any z > 0. The I(n 6¼ 2x) denotes the indicator
function that equals 1 if (n 6¼ 2x), and 0 otherwise.
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